Literature DB >> 21196176

Evidence for cancer stem cells contributing to the pathogenesis of ovarian cancer.

Michael D Curley1, Leslie A Garrett, John O Schorge, Rosemary Foster, Bo R Rueda.   

Abstract

Ovarian cancer represents the most lethal gynecologic malignancy, primarily due to a lack of early detection, which results in most patients being diagnosed at an advanced stage of disease. Though the ovarian surface epithelium is thought to provide the primary site of tumorigenesis, the exact etiology of the various tumor types associated with this disease remain undefined. Recent evidence suggests that ovarian tumors, like other solid tumors, contain distinct populations of cells that are responsible for tumor initiation, maintenance and growth. These specialized cells, termed cancer stem cells, display some of the hallmarks of normal stem cells and are thought to evade current chemotherapeutic strategies, resulting in an increased risk of recurrence. Here we review evidence for the existence of cancer stem cells in ovarian malignancies and their contribution to the pathology of this disease, critically evaluate the methods used for ovarian cancer stem cell definition and isolation, and discuss their clinical relevance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21196176     DOI: 10.2741/3693

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  27 in total

1.  CD133 expression associated with poor prognosis in ovarian cancer.

Authors:  Jing Zhang; Xiaoqing Guo; Doo Young Chang; Daniel G Rosen; Imelda Mercado-Uribe; Jinsong Liu
Journal:  Mod Pathol       Date:  2011-11-11       Impact factor: 7.842

2.  Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.

Authors:  Suping Zhang; Bing Cui; Hsien Lai; Grace Liu; Emanuela M Ghia; George F Widhopf; Zhuhong Zhang; Christina C N Wu; Liguang Chen; Rongrong Wu; Richard Schwab; Dennis A Carson; Thomas J Kipps
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-19       Impact factor: 11.205

3.  ALDH enzymatic activity and CD133 positivity and response to chemotherapy in ovarian cancer patients.

Authors:  Francesca Ricci; Sergio Bernasconi; Luca Porcu; Eugenio Erba; Nicolò Panini; Robert Fruscio; Federica Sina; Valter Torri; Massimo Broggini; Giovanna Damia
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

4.  Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression.

Authors:  Amy P N Skubitz; Elizabeth P Taras; Kristin L M Boylan; Nate N Waldron; Seunguk Oh; Angela Panoskaltsis-Mortari; Daniel A Vallera
Journal:  Gynecol Oncol       Date:  2013-05-27       Impact factor: 5.482

5.  CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis.

Authors:  Jing Zhang; Bin Chang; Jinsong Liu
Journal:  Hum Pathol       Date:  2013-05-07       Impact factor: 3.466

6.  The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells.

Authors:  Dongming Liang; Yuanyuan Ma; Jian Liu; Claes Goran Trope; Ruth Holm; Jahn M Nesland; Zhenhe Suo
Journal:  BMC Cancer       Date:  2012-05-29       Impact factor: 4.430

7.  Repopulation of ovarian cancer cells after chemotherapy.

Authors:  Carlos M Telleria
Journal:  Cancer Growth Metastasis       Date:  2013-02-18

8.  The peritoneal tumour microenvironment of high-grade serous ovarian cancer.

Authors:  D Andrew Leinster; Hagen Kulbe; Gemma Everitt; Richard Thompson; Mauro Perretti; Felicity N E Gavins; Dianne Cooper; David Gould; Darren P Ennis; Michelle Lockley; Iain A McNeish; Sussan Nourshargh; Frances R Balkwill
Journal:  J Pathol       Date:  2012-04-18       Impact factor: 7.996

9.  Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden.

Authors:  Khalid Abubaker; Ardian Latifi; Rod Luwor; Simon Nazaretian; Hongjian Zhu; Michael A Quinn; Erik W Thompson; Jock K Findlay; Nuzhat Ahmed
Journal:  Mol Cancer       Date:  2013-03-27       Impact factor: 27.401

10.  Stem cell-like gene expression in ovarian cancer predicts type II subtype and prognosis.

Authors:  Matthew Schwede; Dimitrios Spentzos; Stefan Bentink; Oliver Hofmann; Benjamin Haibe-Kains; David Harrington; John Quackenbush; Aedín C Culhane
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.